|
|
|
|
|
|
Cellular mechanisms of Insulin resistance in type 2 diabetes mellitus and the metabolic syndrome | Gerald I. Shulman (Yale University, USA) |
|
|
|
|
|
|
|
|
Mothers with diabetes, obesity or malnutrition have offspring with metabolic syndrome. Can similar mechanisms be involved? | Mechanisms Be Involved? | Boyd E. Metzger (Northwestern University, USA) |
|
|
|
|
|
|
|
|
Selective insulin resistance - Common cause of diabetic cardiac and vascular diseases | | George L. King (Harvard University, USA) |
|
|
|
|
|
|
|
|
1) Treatment of type 2 diabetes | Kitt F.Petersen (Yale University, USA) |
2) New roles of an old enzyme: NAD(P)H:quinone oxidoreductase 1 as an interesting drug target for | metabolic syndrome | 송민호 (충남의대) |
3) Modulation of insulin sensitivity by DGAT1 and triglyceride synthesis in skeletal muscle | Yi-Hao Yu (Columbia University, USA) |
1) Ceramide modulates lipid and glucose metabolism in cardiovascular system: new therapeutic target for | cardiovascular disease | 박태식 (Columbia University, USA) |
2) Pyruvate dehydrogenase kinase 4 as a major determinant of skeletal muscle insulin sensitivity | 윤장현 (University of Southern California, USA) |
3) Enhancing fat oxidation and inhibiting fat synthesis may offer potential therapeutic strategies for obesity | and the metabolic syndrome | 최철수 (Yale University, USA) |
4) Molecular targets for the treatment of metabolic syndrome | 김민선 (울산의대) |
1) Novel mediators of skeletal muscle metabolism: AMPK, LKB1 and TRB3 | Laurie J. Goodyear (Harvard University, USA) |
2) Exercise management for non-diabetic and diabetic obese patients | 민경완 (을지의대) | 3) Dietary management for non-diabetic and diabetic obese patients | 이관우 (아주의대) |
1) The role of the endocannabinoid system in food intake and metabolic regulation: Basic and clinical | concepts | Gary Wittert (University of Adelaide, Australia) |
2) The optimizing strategies to treat obesity and metabolic syndrome for Korean obese patients | 김영설 (경희의대) |
3) Understanding incretins and the role of improving metabolic syndrome | 윤건호 (가톨릭의대) |
4) Potential of the new DPP-4 inhibitors in metabolic syndrome | 우정택 (경희의대) |
1) The metabolic syndrome, diabetes and cardiovascular disease: The role of TZDs in modifying disease | progression | Peter Grant (University of Leeds, UK) |
2) Angiotensin receptor blockers: New considerations in their mechanism of action in focus of treatment of | metabolic syndrorme | Bobby V. Khan (Emory University, USA) |
3) Role of lipid-lowering drugs in managing CVD risk in diabetes and metabolic syndrome | Paul N. Durrington (University of Manchester, UK) |
4) Metabolic dysregulation as a cause for contractile dysfunction of the heart in obesity and diabetes: | Is this a potential target for therapy? | Gary D. Lopaschuk (University of Alberta, Canada) |
|
|
|
|
|
|
|
|
1) Rationale behind treatment with insulin pumps - and continuous glucose monitoring | Lristen Norgaard (Hvidovre Hospital, Denmark) |
2) Choosing a path on a journey to a full automatic artificial pancreas | Garry Steil (Meditronics Minimed, USA) |
3) 유비쿼터스 헬스케어 시스템의 현재와 미래 | 조재형 (가톨릭의대) |
|
|
|
|
|
|
|
|
위원회 / 소연구회 심포지엄 주제: Diabetes in Young Women 1) 당뇨병 환자의 임신과 출산 | 김정국 (경북의대) |
2) 임신성 당뇨병 | 장학철 (서울의대) | 3) 다낭난소증후군 | 홍영선 (이화의대) | 4) 젊은 여성 당뇨병환자의 심리사회적 특성 | 김준영 (한강성심병원) |
주제: 당뇨병 합병증의 발병 기전 1) 당뇨병 합병증의 발병 기전 | 정인경 (경희의대) |
2) 당뇨병성 신증의 치료 | 이지현 (대구가톨릭의대) | 3) 당뇨병성 망막증의 치료 | 조영민 (서울의대) | 4) 대혈관 합병증 예방을 위한 항혈소판 치료 | 김효정 (을지의대) |
주제: 지질대사의 이해와 응용 1) 당뇨병에서 변화되는 지질대사 | 김인주 (부산의대) |
2) 신인류 다이어트: 거대영양소의 황금비율 | 박용우 (성균관의대) | 3) 콜레스테롤을 낮추는 식사 | 임현숙 (인하대학교병원) |
주제: 적절한 치료지침을 위한 근거 확립에 대한 임상 및 코호트 연구의 현황 1) Clinical features of Japanese patients with type 2 diabetes from Japan Diabetes Complications Study | (JDCS) | Hirohito Sone (Ochanomizu University, Japan) |
2) 한국Cohort 연구현황(KNDP를 중심으로) | 김영설 (경희의대) | 3) Panel Discussion | |
주제: 심평원 자료를 이용한 당뇨병 기초통계연구 TFT 연구결과 및 2007년도 연구 설계 / 토의 1) 연구보고서 ‘Diabetes in Korea 2007, 1st Edition‘ 예비 보고 | 박이병 (가천의대) |
2) 2005년 조사연구결과 심층분석: 관리현황, 의료비용 및 사망통계 | 백세현 (고려의대) | 3) 당뇨병기초통계TFT 제2차 전국조사 수행계획 | 김재용 (건강보험심사평가원) |
주제: Insulin Resistance and Metabolic Syndrome 1) The role of mitochondrial dysfunction in metabolic syndrome and type 2 diabetes | Kitt F. Petersen (Yale University, USA) |
2) Gestational diabetes and future metabolic syndrome: What are the issues? | Boyd E. Metzger (Northwestern University, USA) |
3) Current status of metabolic syndrome in Korea | 임 수 (서울의대) |
주제: Strategies for pancreatic beta-cell protection and regeneration 1) Involvement of Ca2+ - mediated apoptotic signals in palmitate-induced MIN6N8a beta cell death | 강 엽 (아주의대 의과학연구소) |
2) Immunoprotection of transplanted pancreatic islets using PEGylation | 변영로 (서울약대 제약학과) |
3) The gut-pancreas connection and its relevance to diabetes | Josephine M. Egan (National Institute of Health, USA) |
주제: 혈관세포와 산화 스트레스 1) Mitochondrial oxidative dysfunction in the diabetic macrovascular complications | 박근규 (계명의대) |
2) Anti-oxidative and Anti-inflammatory Effects of Phosphodiesterase type III inhibitor | 홍기환 (부산의대) |
3) α-Lipoic acid suppresses endothelial cell senescence by elevating nitric oxide production | 김영명 (강원의대) |
주제: 자가 관리 실태에 관한 조사 1) 저혈당으로 응급실을 내원한 당뇨병 환자의 저혈당 발생의 주요요인과 치료비용 | 이정림 (서울아산병원) |
2) 주사기 및 펜 니들의 사용실태 조사 | 노나리 (신촌세브란스병원) | 3) 자가혈당 측정 및 란셋의 사용실태 조사 | 진혜경 (단국대학교병원) |
4) 당뇨병 약물의 복용 실태 조사 | 홍명희 (서울백병원) |
|